New York, NY -- (SBWire) -- 04/18/2016 --Gastroparesis, also called delayed gastric emptying, is a disorder that slows or stops the movement of food from the stomach to small intestine. Gastroparesis is generally caused under diabetic condition. It is affecting people with both type 1 and type 2 diabetes in which the stomach takes too long to empty its contents. Other unique reasons for gastroparesis comprise intestinal surgery and nervous system diseases such as parkinson's disease, multiple sclerosis, thyroid disease, scleroderma, pancreatitis, imbalances in blood minerals such as calcium, magnesium or potassium, damage of the vagus nerve and others. The primary symptoms associated with this disorder include nausea, vomiting, post-prandial fullness and bloating. Gastroparesis is difficult to diagnose in early stages because most of its symptoms seem common. As currently available treatment options for diabetic gastroparesis are inadequate, new treatments are needed to support increasing prevalence of gastroparesis. This has diverted focus of pharmaceutical companies to invest on issues such as gastroparesis this market to develop new drugs that are safer and more effective than ever before and expected significant growth in the global market value over the forthcoming years.
Increasing prevalence of diabetic gastroparesis, growing ageing population, and high demand for drugs are the major drivers for the growth of global diabetic gastroparesis market. However, limited availability of treatment options, weak gastroparesis pipeline drugs, and usage of off-label therapies for gastroparesis treatment are expected to hamper the growth of this market.
The global diabetic gastroparesis market is segmented based on type of disease, drugs, and applications.
Based on indication type,
Mild gastroparesis
Compensated gastroparesis
Gastric Failure
Based on treatment type,
First Line Treatment
Prokinetic/Pro-motility Agents
Cisapride
Domeperidone
Metoclopramide
Erythromycin
Antiemetic Agents
Serotonin 5-HT3 Receptor Antagonists,
Antihistamines
Phenothiazines
Low-Dose Tricyclic Antidepressants
Botulinum Toxin Injection
Second Line Treatment
Traditional Surgery
Electrical pacing
venting gastrostomy
Gastric Electrical Stimulation
Based on end user type,
Hospitals
Intensive Care Unit
Surgical Units
Ambulatory Surgical centers
Interested in report: Please follow the below the links to meet your requirements; Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/10082
Treatement of diabetic gastroparesis depends on the severity of person's symtomps. Numerous prescription medications are available to cure gastroparesis. Drug combinations may be used to find the most effective treatment. Under first line treatment segment, there are four oral drugs (Cisapride, Domeperidone, Metoclopramide, and Erythromycin) that are commonly used to stimulate contractions of the stomach's muscle, also referred to as pro-motility drugs. Under second line treatment segment, gastric electrical stimulation is effective in gastroparesis patients suffering from nausea and other side effects. Surgery is used occasionally to treat gastroparesis. Due to rapidly increasing prevalence of diabetic gastroparesis, it is expected that the demand for these drugs will increase significantly and ultimately fuel the market value of global diabetic gastroparesis market over the forecasted period.
Request TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/10082
Depending on geographic region, diabetic gastroparesis market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to dominate the global gastroparesis market followed by Europe. The primary reasons for the same include growing diabetes incidence, increasing treatment awareness for diabetic gastroparesis, and rising contribution of disposable income towards healthcare expenses. However, Asia-Pacific is expected to exhibit strongest growth dynamics in diabetic gastroparesis market due to rising economic affluence in various parts of this region.
Key companies operational in global diabetic gastroparesis market are GlaxoSmithKline plc, Evoke Pharma, Tranzyme Pharma, Targacept, Inc., Salix Pharmaceuticals, Inc., Par Pharmaceuticals Companies, Inc., Ipca Laboratories Ltd., Cadila Pharmaceuticals, CFL Pharmaceutical Ltd, Abbott Laboratories, Alembic Pharmaceuticals Limited, and others.
Follow us on LinkedIn: https://www.linkedin.com/company/persistence-market-research-&-consulting
Key points covered in the report
1) Report segments the market on the basis of types, application, products, technology, etc (as applicable)
2) The report covers geographic segmentation
North America
Europe
Asia
RoW
3) The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020
4) The report provides company profiles of some of the leading companies operating in the market
5) The report also provides porters five forces analysis of the market.
About Persistence Market Research
Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.
Global Industry Analysis on Diabetic Gastroparesis Market, 2016 to 2022
Persistence Market Research Pvt. Ltd is released new forthcoming report on title "Diabetic Gastroparesis Market: Global Industry Analysis and Forecast 2016 - 2022".